Health

All Health

  • FDA deadlines may compromise drug safety by rushing approvals

    Many medications are approved by the U.S. Food and Drug Administration (FDA) on the brink of congressionally mandated deadlines, and those drugs are more likely to face later regulatory intervention than those approved with greater deliberation, researchers at Harvard University have found. Drugs fast-tracked by the FDA are more likely to eventually be withdrawn from global markets for safety reasons, undergo manufacturing revisions, or face labeling changes, according to Daniel Carpenter, professor of government in Harvard’s Faculty of Arts and Sciences. The research was published in the March 27 issue of the New England Journal of Medicine.

  • Eating meat led to smaller stomachs, bigger brains

    Behind glass cases, Harvard’s Peabody Museum of Archaeology displays ancient tools, weapons, clothing, and art — enough to jar you back into the past. But the venerable museum offered a jarring moment of another sort in its Geological Lecture Hall last month (March 20). Paleoanthropologist Leslie Aiello delivered a late-afternoon talk on diet, energy, and evolution. It was jolting to see her, slight and matronly, stand before a story-high screen filled with images of rugged early hominids on a savannah, gathered around fallen game.

  • Common aquatic animals show resistance to radiation

    Scientists at Harvard University have found that a common class of freshwater invertebrate animals called bdelloid rotifers are extraordinarily resistant to ionizing radiation, surviving and continuing to reproduce after doses of gamma radiation much greater than that tolerated by any other animal species studied to date.

  • Scientists learn what’s ‘up’ with retinal cells

    Harvard University researchers have discovered a new type of retinal cell that plays an exclusive and unusual role in mice: detecting upward motion. The cells reflect their function in the physical arrangement of their dendrites, branchlike structures on neuronal cells that form a communicative network with other dendrites and neurons in the brain.

  • Louise Ivers: ‘I can’t sleep at night because of the things that I see.’

    Louise Ivers gently lifted the 7-month-old by his forearms, hoping he would pull himself up as a healthy child a third his age might. But his head hung limply back,…

  • Newly discovered class of mouse retinal cells detect upward motion

    Harvard researchers have discovered a previously unknown type of retinal cell that plays an exclusive and unusual role in mice: detecting upward motion. The cells reflect their function in the…

  • Satcher’s goal: To help ‘people who have been left out’

    David Satcher — the 16th U.S. surgeon general and co-author of “Multicultural Medicine and Health Disparities” (McGraw-Hill, 2006), was in Boston (March 13) to deliver the fourth in a 2007-08 series of lectures in Public Health Practice and Leadership sponsored by the HSPH’s Division of Health Practice.

  • Link between deep sleep and visual learning

    A relationship has been observed between deep sleep and the ability of the brain to learn specific tasks. Researchers at Harvard-affiliated Brigham and Women’s Hospital (BWH) have now shown that the processes that regulates deep sleep may affect visual learning. These results are published in the March 12 issue of the Journal of Neuroscience.

  • Study shows indicator for cardiovascular events

    A study appearing in this week’s (March 19) New England Journal of Medicine (NEJM) confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients’ cholesterol levels and can signify increased risk of heart attack, stroke, or sudden cardiac death. Led by researchers from the Massachusetts General Hospital (MGH) cardiology division, the study’s findings are a first step toward the ability to identify individuals who might benefit from earlier use of cholesterol-lowering medications and other measures to combat elevated risk.

  • MGH initiates Phase I of its diabetes trial

    Scientists at Massachusetts General Hospital (MGH) have initiated a Phase I clinical trial to reverse type 1 diabetes. The trial is exploring whether the promising results from the laboratory of Denise Faustman can be applied in human diabetes.

  • Study: Know thyself and you’ll know others better

    Using functional MRI (fMRI) scanning, researchers have found that the region of the brain associated with introspective thought “lights up” when people infer the thoughts of others like themselves. However, this is not the case when we’re considering people we think of as different politically, socially, or religiously. Published in the current issue of the Proceedings of the National Academy of Sciences, the study was led by Adrianna Jenkins, a graduate student in the Department of Psychology in the Faculty of Arts and Sciences at Harvard University, with Jason Mitchell, assistant professor of psychology at Harvard. Jenkins and Mitchell’s co-author was C. Neil Mcrae of the University of Aberdeen.

  • Punishment doesn’t earn rewards

    Individuals who engage in costly punishment do not benefit from their behavior, according to a new study published this week in the journal Nature by researchers at Harvard University and the Stockholm School of Economics.

  • Increasing U.S. support could save a million South Africans by 2012

    More that 1.2 million deaths could be prevented in South Africa over the next five years by accelerating efforts to provide access to antiretroviral therapy (ART), according to a study released March 13 in the Journal of Infectious Diseases.

  • Stem cells open window on disease processes

    A panel of Harvard Stem Cell Institute experts said recently that stem cell research’s biggest impact on patients’ health likely won’t come from therapies that inject stem cells or implant…

  • MGH receives Gates Foundation grant

    The Massachusetts General Hospital (MGH) has received a five-year, $20.5 million grant from the Bill & Melinda Gates Foundation to expand an international program investigating the biological factors underlying immune system control of HIV, the virus that causes AIDS. The grant provides support to the International HIV Controllers Study, which currently involves researchers from more than a dozen countries and has the overall goal of discovering information that can guide design of a vaccine to limit viral replication in HIV-infected individuals. A primary focus will be to understand the genetic and immunological factors that have allowed a few individuals to control HIV naturally without the need for medications, some for more than 25 years.

  • Late treatment with letrozole can reduce cancer recurrence risk

    Treatment with the aromatase inhibitor letrozole (Femara) can reduce the risk of breast cancer recurrence even when initiated one to seven years after a course of tamoxifen therapy. The results of a study involving women originally in the placebo arm of an international trial of letrozole will appear in the Journal of Clinical Oncology and are receiving early online release. Among those who chose to begin letrozole treatment after the initial trial was halted, the risk that their cancer would recur was cut in half compared with those who never received letrozole. In addition, the risk of metastasis was 60 percent lower with letrozole, and the chance that a new tumor would develop in the unaffected breast dropped more than 80 percent.

  • Protein folding: Life’s vital origami

    The way proteins fold, and the good and bad effects of this molecular phenomenon, are what keeps biologist Susan L. Lindquist busy. Lindquist Ph.D. ’76, a Radcliffe Fellow this year, is an award-winning professor and researcher at the Massachusetts Institute of Technology (MIT) and a former director of the Whitehead Institute. She shared her insights on protein folding with an audience of 70 last week (March 5) at the fellowship program’s 34 Concord Ave. headquarters.

  • Harvard faculty members discuss state of research

    A panel of experts said Tuesday (March 11) that stem cell research’s biggest impact on patients’ health likely won’t come from therapies that inject stem cells or implant tissues made from them, but rather from the knowledge gained by examining diseased tissues grown from the cells.

  • Inhaled TB vaccine more effective than traditional shot

    A novel aerosol version of the most common tuberculosis (TB) vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental animals than a comparable dose of the traditional injected vaccine, researchers report this week (March 12) in the Proceedings of the National Academy of Sciences (PNAS). The aerosol vaccine — under development through a collaboration between Harvard University and the international not-for-profit Medicine in Need (MEND) — could provide a low-cost, needle-free TB treatment that is highly stable at room temperature.

  • Sobering look at ‘mind-body connection’

    Mind-body medicine goes by many names today — including holistic, complementary, or alternative medicine. Regardless of what it’s called, many people embrace the ideas behind the mind-body connection and its effect on health, sometimes despite a lack of supporting scientific evidence. In her recently published book, “The Cure Within: A History of Mind-Body Medicine” (W.W. Norton and Company, 2008), Anne Harrington explores the long-lived and widespread belief in these unconventional medical practices.

  • President testifies for increase in NIH funding

    With the careers of a generation of young researchers threatened by five years of flat National Institutes of Health (NIH) funding, Harvard President Drew Faust and leaders of six other major research institutions were in Washington Tuesday (March 11) calling on Congress to repair the “Broken Pipeline” through which breakthroughs in the biomedical sciences should be flowing.

  • Ecologist Jeremy Jackson to receive Roger Tory Peterson Medal

    Jeremy Jackson, renowned marine ecologist of the Scripps Institution of Oceanography, has been selected to receive the 11th annual Roger Tory Peterson Medal presented by the Harvard Museum of Natural History (HMNH). Jackson will deliver the Roger Tory Peterson Memorial Lecture on April 6 at 3 p.m. in the Science Center, 1 Oxford St.

  • Initial human trial of Type 1 diabetes treatment begun

    Scientists at the Massachusetts General Hospital (MGH) have initiated a phase 1 clinical trial to reverse type 1 diabetes. The trial is exploring whether the promising results from the laboratory…

  • Inhaled tuberculosis vaccine may be more effective than injected vaccine

    A novel aerosol version of the most common tuberculosis (TB) vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental animals…

  • HSPH establishes new three-year grant program

    The Harvard School of Public Health (HSPH) has announced the establishment of the A.G. Leventis Foundation Fellowship Program with a three-year grant to support Cypriot/Greek and Nigerian students and scholars in public health.

  • Of flies and fish

    During her schooldays in 1950s Germany, Christiane Nüsslein-Volhard rarely did her homework. In 1995, she won the Nobel Prize for physiology and medicine. Volhard is now director of the prestigious Max Planck Institute for Developmental Biology in Tübingen, where, decades before, she had been an undistinguished biochemistry undergraduate. She was at Harvard this week (March 4) to deliver a talk sponsored by the Radcliffe Institute for Advanced Study as part of its Dean’s Lecture Series.

  • Gene variants probably increase risk for anxiety disorders

    Massachusetts General Hospital (MGH) researchers — in collaboration with scientists at the University of California, San Diego, and Yale University — have discovered perhaps the strongest evidence yet linking variation in a particular gene with anxiety-related traits. In the March issue of Archives of General Psychiatry, the team describes finding that particular versions of a gene that affects the activity of important neurotransmitter receptors were more common in both children and adults assessed as being inhibited or introverted and also were associated with increased activity of brain regions involved in emotional processing.

  • Biologist Venter will be visiting scholar at Origins of Life Initiative

    J. Craig Venter, the visionary biologist and intellectual entrepreneur who was a leading figure in the decoding of the human genome, will join Harvard University as a visiting scholar at the University’s Origins of Life Initiative.

  • HMS, Broad Institute team works to better understand mitochondria

    Why do nearly 1 million people taking cholesterol-lowering statins often experience muscle cramps? Why is it that in the rare case when a diabetic takes medication for intestinal worms, his glucose levels improve? Is there any scientific basis for the purported health effects of green tea?

  • Portion of encyclopedic ‘macroscope’ unveiled

    The first 30,000 pages of a massive online Encyclopedia of Life were unveiled last week at the Technology, Entertainment and Design (TED) conference in Monterey, Calif. The project was congratulated by E.O. Wilson, Pellegrino University Professor Emeritus, who articulated the need for a dynamic modern portrait of biodiversity in a widely read essay in 2003. “The launch of the Encyclopedia of Life will have a profound and creative effect in science,” Wilson said. “It aims not only to summarize all that we know of Earth’s life forms, but also to accelerate the discovery of the vast array that remain unknown.”